More Alzheimer's drug trial failures: are researchers on the wrong track?
(HealthDay)—Amyloid beta has long been a prime suspect in Alzheimer's disease, since abnormal levels of the protein form disruptive plaques between patients' brain cells.
Apr 10, 2019
1
9